Literature DB >> 28470354

Small interfering RNA targeting receptor for advanced glycation end products protects the rats from multibacterial sepsis.

X Zhao1, Y N Liao1, Q Huang2.   

Abstract

BACKGROUND: Sepsis is a major challenge in clinical medicine, and treatment options are limited. Recently, the receptor for advanced glycation end products (RAGE) appears to be an excellent target for new therapeutic agents. AIMS: The objective of this study is to investigate the effect of small interfering RNA (siRNA) targeting RAGE on the outcome of multibacterial sepsis induced by cecal ligation and puncture (CLP) in a rat model.
METHODS: A vector-based RAGE-targeted siRNA expression system (Psilencer-siRNA) was constructed and injected into rats via the jugular vein catheter after CLP injury. The RAGE expression in livers, survival rate, and plasma cytokine levels after CLP were compared between Psilencer-siRNA treated and control rats.
RESULTS: The expression of RAGE in livers which was upregulated after CLP injury was greatly curtailed by Psilencer-siRNA administration. Compared to control rats, the Psilencer-siRNA-treated rats had significantly higher survival rate (p < 0.05) and markedly decreased plasma cytokine levels (p < 0.001) after CLP.
CONCLUSIONS: Targeting RAGE by siRNA might attenuate hyperinflammation, improve survival rate, and offer new therapeutic options for sepsis.

Entities:  

Keywords:  Cecal ligation and puncture; Receptor for advanced glycation end products; Sepsis; Small interfering RNA

Mesh:

Substances:

Year:  2017        PMID: 28470354     DOI: 10.1007/s11845-017-1613-0

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  12 in total

1.  Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response.

Authors:  Birgit Liliensiek; Markus A Weigand; Angelika Bierhaus; Werner Nicklas; Michael Kasper; Stefan Hofer; Jens Plachky; Herman-Josef Gröne; Florian C Kurschus; Ann Marie Schmidt; Shi Du Yan; Eike Martin; Erwin Schleicher; David M Stern; G ünterJ Hämmerling G; Peter P Nawroth; Bernd Arnold
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

2.  The effect of sRAGE-Fc fusion protein attenuates inflammation and decreases mortality in a murine cecal ligation and puncture model.

Authors:  Su Jin Jeong; Beom Jin Lim; Sungha Park; Donghoon Choi; Hye Won Kim; Nam Su Ku; Sang Hoon Han; Chang Oh Kim; Jun Yong Choi; Young Goo Song; June Myung Kim
Journal:  Inflamm Res       Date:  2012-07-10       Impact factor: 4.575

Review 3.  Animal models of sepsis: setting the stage.

Authors:  Jon A Buras; Bernhard Holzmann; Michail Sitkovsky
Journal:  Nat Rev Drug Discov       Date:  2005-10       Impact factor: 84.694

4.  Immunodesign of experimental sepsis by cecal ligation and puncture.

Authors:  Daniel Rittirsch; Markus S Huber-Lang; Michael A Flierl; Peter A Ward
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

5.  Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding.

Authors:  Kendra N Iskander; Marcin F Osuchowski; Deborah J Stearns-Kurosawa; Shinichiro Kurosawa; David Stepien; Catherine Valentine; Daniel G Remick
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

Review 6.  Sepsis: pathophysiology and clinical management.

Authors:  Jeffrey E Gotts; Michael A Matthay
Journal:  BMJ       Date:  2016-05-23

7.  RNA interference in adult mice.

Authors:  Anton P McCaffrey; Leonard Meuse; Thu-Thao T Pham; Douglas S Conklin; Gregory J Hannon; Mark A Kay
Journal:  Nature       Date:  2002-07-04       Impact factor: 49.962

Review 8.  The role of receptor for advanced glycation endproducts (RAGE) in infection.

Authors:  Marieke A D van Zoelen; Ahmed Achouiti; Tom van der Poll
Journal:  Crit Care       Date:  2011-03-22       Impact factor: 9.097

Review 9.  The RAGE axis in systemic inflammation, acute lung injury and myocardial dysfunction: an important therapeutic target?

Authors:  Benedict C Creagh-Brown; Gregory J Quinlan; Timothy W Evans; Anne Burke-Gaffney
Journal:  Intensive Care Med       Date:  2010-07-15       Impact factor: 17.440

10.  Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection.

Authors:  Emily C Lutterloh; Steven M Opal; Debra D Pittman; James C Keith; Xiang-Yang Tan; Brian M Clancy; Helen Palmer; Kim Milarski; Ying Sun; John E Palardy; Nicholas A Parejo; Noubar Kessimian
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.